ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q4SCImago #27,778Review JournalHybrid

SA Pharmaceutical Journal

Identifier (ISSN):2221-5875(Print)/2220-1017(Online)
•
Publisher:Medpharm Publications Ltd.
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.5↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for SA Pharmaceutical Journal

WoS Q4
00110.220230.220240.320250.52026
Annual Impact Factor Metric
Current (2026):0.5
Scopus SJR & RankScopus Q4
0.125
#27,778

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
10

10 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
23articles/year
64.6% Gold OA•0% Original Research

Aims & Scope

SA Pharmaceutical Journal (ISSN: 2221-5875) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Medpharm Publications Ltd. in South Africa. The periodical holds a Journal Impact Factor (JIF) of 0.50, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.125 (Q4), an H-index of 10.

Topics Covered (Recognized by AI)
Medicine92.5%Biology57.8%Political science46%Law44.5%Internal medicine40.5%Psychology37%Nursing35.7%Family medicine34.8%Economics31%Pathology30.6%Pharmacy25.1%Psychiatry23.7%Computer science22.7%Intensive care medicine22.6%Genetics20.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank346/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank354/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

16 year
2026Latest
IF0.5
Articles / Year—
Total Citations—
2025
IF0.3
Articles / Year—
Total Citations—
2024
IF0.2
Articles / Year—
Total Citations—
2023
IF0.2
Articles / Year—
Total Citations—
2021
IF—
Articles / Year3
Total Citations0

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #27,778Scopus Q4SCImago Profile
Scopus Coverage:2009-2025
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q4
0.125

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4
Citations / Doc (2 years)
0.24

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,257 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations39
3-Year Documents199
Citable Documents142

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate57.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

SA Pharmaceutical Journal (ISSN: 2221-5875) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Medpharm Publications Ltd. in South Africa. The periodical holds a Journal Impact Factor (JIF) of 0.50, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.125 (Q4), an H-index of 10.

The journal enforces rigorous peer evaluation with an annual output of approximately 23 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,257 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Medpharm Publications Ltd.
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6691e313-12a3-4992-84f1-7da360edc141
Database Updated: 2026-09-29